Dr. Pathik Parikh Hepatologist and Liver Transplant Physician

  Fatty Liver is no longer an unheard term. The prevalence of fatty liver in India is approximately 30% and that means that nearly one in three person suffers from it. The disease is not as benign as the name and prevalence suggest. This disease is the most common liver disease worldwide. It is on path to become the number 1 reason for liver cirrhosis, liver cancer and liver transplant. New Terminology The disease has gone significant change in terminology and is now known as  MASLD – Metabolic-Dysfunction Associated Steatotic Liver Disease  and recently in 2023 the experts of the world met and proposed the following terminology for types of  SLD (Steatotic Liver Disease)  or  Fatty Liver Disease MASLD – Previously NAFLD or Fatty Liver MASH – Previously NASH MetALD – No previous terminology (Patients also take alcohol in addition). Risk Factors MASLD and MASH is usually seen in patients who are obese, overweight and suffer from diabetes, hypertension, sedentary lifestyle, thyroid disea